<DOC>
	<DOCNO>NCT02531204</DOCNO>
	<brief_summary>The purpose study assess bioequivalence ASP1585 granules ASP1585 capsule repeat oral administration ASP1585 granules ASP1585 capsule open-label condition non-elderly healthy male subject . In addition , safety product assess .</brief_summary>
	<brief_title>A Study ASP1585 Evaluate Bioequivalence Between ASP1585 Granules ASP1585 Capsules</brief_title>
	<detailed_description />
	<criteria>Body weight ( screen ) ≥ 50.0 kg &lt; 80.0 kg Body mass index ( BMI ) ( screen ) ≥ 17.6 kg/m2 &lt; 26.4 kg/m2 Healthy , judge investigator/subinvestigator base medical history result physical examination ( subjective symptom objective finding ) test obtain screen period hospital admission immediately study medication 1st period . Received schedule receive investigational drug clinical trial , postmarketing study , clinical study within 120 day screen period screen 1st hospitalization . Donated schedule donate 400 mL whole blood within 90 day screen period screen 1st hospitalization , 200 mL whole blood within 30 day screen period screen 1st hospitalization , blood component within 14 day screen period screen 1st hospitalization . Any deviation laboratory test screen 1st hospitalization . A deviation normal range blood pressure , pulse rate , body temperature screen 1st hospitalization Sitting blood pressure : Systolic blood pressure : ≥90 mmHg , ≤140 mmHg ; Diastolic blood pressure : ≥40 mmHg , ≤90 mmHg Sitting pulse rate ; ≥40 bpm , ≤99 bpm Axillary body temperature ; ≥35.0°C , ≤37.0°C History drug allergy Upper gastrointestinal disease ( e.g. , nausea , vomit , stomachache ) within 7 day 1st hospitalization Concurrent previous hepatic disease ( e.g. , viral hepatitis , druginduced liver injury , hepatic impairment ) Concurrent previous heart disease ( e.g. , congestive heart failure , angina pectoris , arrhythmia require treatment ) Concurrent previous GI disease ( e.g. , ileus paralytic , gastric atony , intestinal atony , colitis ulcerative , peptic ulcer gastroesophageal reflux esophagitis ; except history appendicitis ) . Concurrent previous renal disease ( e.g. , acute renal failure , glomerulonephritis , interstitial nephritis ) Concurrent previous renal disease ( e.g. , acute renal failure , glomerulonephritis , interstitial nephritis ) Concurrent previous cerebrovascular disorder ( e.g. , cerebral infarction ) Previous use bixalomer Excessive smoking drinking habit</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>ASP1585</keyword>
	<keyword>Bioequivalence</keyword>
	<keyword>Pharmacodynamic</keyword>
	<keyword>Phosphate binder</keyword>
	<keyword>Bixalomer</keyword>
	<keyword>urinary phosphorus excretion</keyword>
</DOC>